We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
Cap. Flow
+$144M
Cap. Flow %
3.24%
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6 years
Top 10 Avg Time Held Equity + Options
2.7 years
Top 20 Avg Time Held Equity + Options
3.7 years
Avg Time Held Equity only
4.6 years
Top 10 Avg Time Held Equity only
2.7 years
Top 20 Avg Time Held Equity only
3.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.84%
2 Technology 15.96%
3 Healthcare 9.75%
4 Financials 7.52%
5 Communication Services 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FV icon
2926
First Trust Dorsey Wright Focus 5 ETF
FV
$3.81B
$2.25K ﹤0.01%
41
– –
2022 Q2
11 quarters
FFWM icon
2927
DELISTED
First Foundation Inc
FFWM
$2.24K ﹤0.01%
432
-428
-50% -$2.3K
2022 Q4
9 quarters
BRSL icon
2928
Brightstar Lottery PLC
BRSL
$1.74B
$2.23K ﹤0.01%
+137
New +$2.36K
2025 Q1
0 quarters
APPN icon
2929
Appian
APPN
$2.95B
$2.22K ﹤0.01%
77
-17
-18% -$556
2018 Q3
26 quarters
SWIM icon
2930
Latham Group
SWIM
$720M
$2.22K ﹤0.01%
+345
New +$2.32K
2025 Q1
0 quarters
UDOW icon
2931
ProShares UltraPro Dow 30
UDOW
$929M
$2.22K ﹤0.01%
50
– –
2024 Q2
3 quarters
USFR icon
2932
WisdomTree Floating Rate Treasury Fund
USFR
$20.8B
$2.22K ﹤0.01%
44
– –
2022 Q2
11 quarters
FBT icon
2933
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.87B
$2.21K ﹤0.01%
13
– –
2023 Q3
6 quarters
NABL icon
2934
N-able
NABL
$846M
$2.2K ﹤0.01%
311
+52
+20% +$463
2024 Q2
3 quarters
DNLI icon
2935
Denali Therapeutics
DNLI
$2.81B
$2.2K ﹤0.01%
162
+63
+64% +$1.21K
2023 Q1
8 quarters
PFSI icon
2936
PennyMac Financial
PFSI
$3.13B
$2.2K ﹤0.01%
22
-2
-8% -$205
2021 Q4
13 quarters
RXRX icon
2937
Recursion Pharmaceuticals
RXRX
$1.86B
$2.2K ﹤0.01%
393
+75
+24% +$547
2023 Q2
7 quarters
YEXT icon
2938
Yext
YEXT
$683M
$2.2K ﹤0.01%
357
+54
+18% +$349
2019 Q3
22 quarters
SDGR icon
2939
Schrodinger
SDGR
$1.69B
$2.19K ﹤0.01%
111
+47
+73% +$1.06K
2023 Q3
6 quarters
NWBI icon
2940
Northwest Bancshares
NWBI
$2.19B
$2.18K ﹤0.01%
182
– –
2017 Q2
31 quarters
RPAY icon
2941
Repay Holdings
RPAY
$334M
$2.16K ﹤0.01%
+388
New +$2.67K
2025 Q1
0 quarters
SCSC icon
2942
Scansource
SCSC
$1.21B
$2.14K ﹤0.01%
+63
New +$2.57K
2025 Q1
0 quarters
NUVL icon
2943
DELISTED
Nuvalent
NUVL
$2.13K ﹤0.01%
30
+29
+2,900% +$2.27K
2024 Q3
2 quarters
EGBN icon
2944
Eagle Bancorp
EGBN
$864M
$2.12K ﹤0.01%
102
– –
2023 Q2
7 quarters
RUM icon
2945
RUM Group Inc
RUM
$2.28B
$2.12K ﹤0.01%
300
– –
2022 Q3
10 quarters
GRW icon
2946
TCW ETF Trust TCW Durable Growth ETF
GRW
$62.2M
$2.12K ﹤0.01%
+64
New +$2.15K
2025 Q1
0 quarters
OIS icon
2947
Oil States International
OIS
$490M
$2.12K ﹤0.01%
+411
New +$2.16K
2025 Q1
0 quarters
DGII icon
2948
Digi International
DGII
$2.65B
$2.12K ﹤0.01%
+76
New +$2.34K
2025 Q1
0 quarters
HBI icon
2949
DELISTED
Hanesbrands
HBI
$2.11K ﹤0.01%
366
-302
-45% -$2.12K
2020 Q1
20 quarters
QCRH icon
2950
QCR Holdings
QCRH
$1.62B
$2.1K ﹤0.01%
29
– –
2020 Q2
19 quarters

Similar funds

Parallel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.

  • Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
  • Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
  • Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
  • Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
  • Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
  • Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.